Clinical Pharmacology of Miami   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Miami FL United States (2006)

Organization Overview

First Clinical Trial
2010
NCT01115920
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Climincal Pharmacology of Miami Inc | Clinical Pharmacology of Miami, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatic Encephalopathy (Phase 4)

Hepatic Insufficiency (Phase 4)

Hepatitis (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Liver Diseases (Phase 1)

Liver Failure (Phase 4)

Renal Insufficiency (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 19
  • # of Trial APIs: 17